Univariate and multivariate analyses showed that FBXL6 was strongly associated with overall survival (OS) in HCC patients, supporting the idea that FBXL6 expression is an independent risk factor in HCC (Fig. 1c, Supplementary Table 2). This evidence concerns the gene FBXL6 and hepatocellular carcinoma.